Chemoinformaics analysis of Dibutyl trisulfide
Molecular Weight | 210.433 | nRot | 8 |
Heavy Atom Molecular Weight | 192.289 | nRig | 0 |
Exact Molecular Weight | 210.057 | nRing | 0 |
Solubility: LogS | -5.557 | nHRing | 0 |
Solubility: LogP | 3.964 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 34.0623 |
nHD | 0 | BPOL | 20.5177 |
QED | 0.424 |
Synth | 2.864 |
Natural Product Likeliness | 0.388 |
NR-PPAR-gamma | 0.051 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.008 |
Pgp-sub | 0.017 |
HIA | 0.003 |
CACO-2 | -4.428 |
MDCK | 0.0000238 |
BBB | 0.602 |
PPB | 0.866202 |
VDSS | 1.304 |
FU | 0.0708747 |
CYP1A2-inh | 0.908 |
CYP1A2-sub | 0.919 |
CYP2c19-inh | 0.976 |
CYP2c19-sub | 0.876 |
CYP2c9-inh | 0.825 |
CYP2c9-sub | 0.89 |
CYP2d6-inh | 0.209 |
CYP2d6-sub | 0.769 |
CYP3a4-inh | 0.109 |
CYP3a4-sub | 0.181 |
CL | 12.01 |
T12 | 0.119 |
hERG | 0.199 |
Ames | 0.382 |
ROA | 0.125 |
SkinSen | 0.95 |
Carcinogencity | 0.343 |
EI | 0.993 |
Respiratory | 0.961 |
NR-Aromatase | 0.044 |
Antiviral | No |
Prediction | 0.9178 |